Prof. Rehab Hegazy
About me
Professor of Pharmacology and Secretary-General at the Institute of Medical Research and Clinical Studies, National Research Centre (NRC), Egypt. Her work focuses on translational research, drug safety, and evidence-based medicine, with a strong track record of peer-reviewed publications across multiple areas of pharmacology and drug development. Former Visiting Scholar at St. John’s University (USA) and Harvard ECSRT alumna (Top 3). International conference speaker and Appointed Council Member of the Supreme Council of Clinical Pharmacy (Military Medical Academy, Egypt).
Professor Rehab Hegazy is a Professor of Pharmacology and Secretary-General of the Institute of Medical Research and Clinical Studies at the National Research Centre (NRC), Egypt. Her work is centered on advancing translational research that bridges scientific discovery with clinical practice and societal impact, with a strong focus on clinical pharmacology, drug safety, and evidence-based medicine.
Her academic and research expertise spans pharmacovigilance, experimental animal models, and the preclinical evaluation of safety, efficacy, and therapeutic outcomes, alongside the development and optimization of research models that support robust and reproducible drug-related investigations. She has led and contributed to numerous multidisciplinary research projects designed to translate laboratory findings into clinically relevant and healthcare-applicable outcomes. Her publication record includes peer-reviewed articles across multiple areas of pharmacology and drug development, reflecting sustained scholarly contributions beyond any single institution or country.
Internationally, Professor Hegazy served as a Visiting Scholar at the College of Pharmacy and Health Sciences, St. John’s University, New York, where she collaborated on research in advanced drug delivery systems and nanomedicine for oncology and targeted therapies. This collaboration resulted in multiple peer-reviewed publications (2023–2024), including work on lipid nanocomplexes, PROTAC formulation strategies, and self-nanoemulsifying drug delivery systems for cancer therapy. One of these studies, published in the Journal of Molecular Liquids (2024), received international media coverage by Cancer Daily (NewsRx), highlighting its translational relevance in liver cancer research.
She completed the Harvard Clinical Scholar Research Training (ECSRT), an advanced program in clinical research methodology, biostatistics, research ethics, and translational medicine, and was ranked among the Top 3 participants with formal recognition for excellence. This training further strengthened her commitment to rigorous, patient-centered clinical research and high standards of scientific integrity.
In parallel with her research activities, Professor Hegazy has made substantial contributions to education and professional training in pharmacology, pharmaceutical medicine, and clinical research. She participated in teaching the professional training programme for physicians and pharmacists on drug development, “Continuing Professional Development in Medicines Development,” delivered in cooperation between King’s College London (UK) and the National Research Centre (Egypt) and funded by the British Council (January–July 2023). She also taught Pharmacoepidemiology within the Clinical Research Diploma (GNCRD 2021) at the General Organization of Teaching Hospitals and Institutes in Egypt. These roles reflect her commitment to capacity building and strengthening the clinical research and medicines development workforce.
Professor Hegazy holds senior leadership responsibilities in medical and academic administration, including strategic planning, institutional governance, quality assurance, and the development of Centers of Medical Excellence. Her leadership work aims to integrate research, clinical services, and community needs within sustainable healthcare frameworks and to strengthen institutional research ecosystems.
Over the past two years, she has been engaged in the marketing administration of research outputs, focusing on positioning, value articulation, and market alignment of applied research results. This experience is supported by a Professional Marketing certification from the American Chamber of Commerce (AmCham), enhancing her ability to translate scientific evidence into decision-relevant formats and support research utilization.
She is an international conference speaker and delegate, actively engaged in global scientific dialogue, partnerships, and knowledge exchange in pharmacology and medical research. She also serves as an Appointed Council Member of the Supreme Council of Clinical Pharmacy at the Military Medical Academy in Egypt, contributing to national-level professional standards, education, and policy-related initiatives in clinical pharmacy.
Across her academic, research, leadership, and professional activities, Professor Hegazy maintains a strong commitment to mentorship, postgraduate supervision, and capacity building, with a particular interest in strengthening research ecosystems, supporting early-career scientists, and advancing evidence-based, patient-centered healthcare.